eli lilly drug news - Search News

Lilly weight-loss drug copycats dealt blow

The Washington Post · 1d

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.

Bloomberg on MSN · 2d

Lilly weight-loss drug copycats dealt blow as shortage ends

Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., threatening to upend the many knockoffs that became popular when patients couldn’t find the brand-name medicines.

What end of Eli Lilly's weight-loss drug shortage means for the competition

The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand.

2d

Lilly's weight-loss drug removed from FDA's shortage list

Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...

2don MSN

Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion

The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...

3d

Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements

Lilly will add the center to a site in Lebanon, Indiana, where it is already spending about $9 billion to improve ...

3don MSN

Eli Lilly to build $4.5 billion Indiana facility for advanced drug manufacturing

Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results